Mind Medicine (MindMed) Inc at Jefferies Healthcare Conference Transcript
Good afternoon, and welcome to the Jefferies 2022 Healthcare Conference. It is my great pleasure to introduce Robert Barrow, CEO of Mind Medicine.
All right. Thank you, everyone, for being here. I will give you a brief rundown of Mind Medicine and who we are and what we're prosecuting as a drug development organization. We're one of the leading organizations developing the psychedelic drug class, it's a drug class that we all know in some manner of another. It's been around for a long time. It really has been untapped and unexplored with rigorous development programs for the better part of last 40 or 50 years since the Controlled Substance Act in the early 1970s.
Mind Medicine was formed to take on more than just a simple narrow approach to this drug class, but to think outside of traditional uses to use this drug class as a foundation on which we can build a robust pipeline of new treatments targeting some of the areas with the biggest unmet medical need.
The backdrop
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
